Bubs Australia gets permanent FDA authorisation for US infant formula sales
Bubs Australia secured permanent authorisation from the U.S. Food and Drug Administration to sell three infant formula products in the U.S., sending shares up 30% to their highest close since mid-February.
Bubs Australia said on Monday it secured permanent authorisation from the U.S. Food and Drug Administration to sell three infant formula products in the country, sending its shares up 30% to their highest close since mid-February. Here are the details: ($1 = 1.3881 Australian dollars)